蛛网膜下腔出血早期脑损伤发病
机制综述

摘要/Abstract

摘要：

【摘要】自发性蛛网膜下腔出血是常见的脑血管疾病，死亡率及致残率高。尽管药物及外科手术技术逐渐进步，但是并没有明显改善存活患者的功能预后。传统的观点认为血管痉挛是蛛网膜下腔出血死亡及致残的主要原因，近年来针对血管痉挛的治疗也有了巨大的进步，但是患者的预后仍然很差。目前国外许多研究发现，早期脑损伤可能是蛛网膜下腔出血预后不良的主要因素。

文章导读： 本文通过阐述蛛网膜下腔出血后早期脑损伤的发病机制，从病理生理机制为蛛网膜下腔出血后不
良预后的原因提供一定的参考。

关键词: 蛛网膜下腔出血; 血管痉挛; 早期脑损伤; 细胞凋亡

Abstract:

【Abstract】 Spontaneous subarachnoid hemorrhage is a common cerebrovascular disease, with high mortality and disability. Although drugs and surgery technology progress gradually, there is no obvious improvement on functional outcomes in survivors. Traditional views consider vasospasm is the main cause of death and disability of subarachnoid hemorrhage, and a great progress has been made in the treatment of vasospasm in recent years, but the prognosis of patients is still bad. At present, many foreign studies have found that early brain injury may be a main factor of poor prognosis of subarachnoid hemorrhage.

Key words: Subarachnoid hemorrhage; Vasospasm; Early brain injury; Cell apoptosis

李朝霞，赵性泉. 蛛网膜下腔出血早期脑损伤发病
机制综述[J]. 中国卒中杂志, 2014, 9(03): 241-.

LI Zhao-Xia, ZHAO Xing-Quan.. Review of Pathogenesis of Early Brain Injury after Subarachnoid Hemorrhage[J]. Chinese Journal of Stroke, 2014, 9(03): 241-.

参考文献

参考文献

1 Al-Khindi T, Macdonald RL, Schweizer TA. Cognitive

and functional outcome after aneurysmal subarachnoid

hemorrhage[J]. Stroke, 2010, 41:e519-e536.

2 Ha ns en-Schwa r t z J, Vajkocz y P, Ma cdona ld

RL, et al. Cerebral vasospasm:looking beyond

vasoconstriction[J]. Trends Pharmacol Sci, 2007,

28:252-256.

3 Wakade C, King MD, Laird MD, et al. Curcumin

attenuates vascular inf lammation and cerebral

vasospasm after subarachnoid hemorrhage in mice[J].

Antioxid Redox Signal, 2009, 11:35-45.

4 Cahill J, Calvert JW, Zhang JH. Mechanisms of early

brain injury after subarachnoid hemorrhage[J]. J

Cereb Blood Flow Metab, 2006, 26:1341-1353.

5 Ayer R, Chen W, Sugawara T, et al. Role of gap

junctions in early brain injury following subarachnoid

hemorrhage[J]. Brain Res, 2010, 1315:150-158.

6 Sehba FA, Pluta RM, Zhang JH. Metamorphosis of

subarachnoid hemorrhage research:from delayed

vasospasm to early brain injury[J]. Mol Neurobiol,

2011, 43:27-40.

7 Ayer R, Zhang J. Connecting the early brain injury

of aneurysmal subarachnoid hemorrhage to clinical

practice[J]. Turk Neurosurg, 2010, 20:159-166.

8 Sehba FA, Bederson JB. Nitric oxide in early brain

injury after subarachnoid hemor rhage[J]. Acta

Neurochir Suppl, 2011, 110:99-103.

9 Zimme rma n n M, Se i fe r t V. Endot hel i n a nd

s u b a r a c h n o i d h emo r r h a g e : a n ov e r v i ew[ J ] .

Neurosurgery, 1998, 43:863-875.

10 Juvela S. Plasma endothelin concentrations after

aneurysmal subarachnoid hemorrhage[J]. J Neurosurg,

2000, 92:390-400.

11 Ostrowski RP, Colohan AR, Zhang JH. Molecular

mechanisms of early brain injury after subarachnoid

hemorrhage[J]. Neurol Res, 2006, 28:399-414.

12 Sehba FA, Fr iedr ich V Jr, Makonnen G, et al.

Acute cerebral vascular injury after subarachnoid

hemorrhage and its prevention by administration of a

nitric oxide donor[J]. J Neurosurg, 2007, 106:321-329.

13 Park S, Yamaguchi M, Zhou C, et al. Neurovascular

p r ot e c t ion r e d u c e s e a r ly b r a i n i nju r y a f t e r

subarachnoid hemorrhage[J]. Stroke, 2004, 35:2412-

2417.

14 Guo Z, Su n X, He Z, e t a l . Rol e of ma t r i x

metalloproteinase-9 in apoptosis of hippocampal

neurons in rats during early brain injury after

subarachnoid hemorrhage[J]. Neurol Sci, 2010, 31:143-

149.

15 Orakcioglu B, Fiebach JB, Steiner T, et al. Evolution

of early perihemorrhagic changes--ischemia vs.

edema:an MRI study in rats[J]. Exp Neurol, 2005,

193:369-376.

16 Lee JY, Keep RF, He Y, et al. Hemoglobin and iron

handling in brain after subarachnoid hemorrhage and

the effect of deferoxamine on early brain injury[J]. J

Cereb Blood Flow Metab, 2010, 30:1793-1803.

17 Loftspring MC. Iron and early brain injury after

subarachnoid hemorrhage[J]. J Cereb Blood Flow

Metab, 2010, 30:1791-1792.

18 Lee JY, Keep RF, Hua Y, et al. Deferoxamine

reduces early brain injury following subarachnoid

hemorrhage[J]. Acta Neurochir Suppl, 2011, 112:101-

106.

19 Yang QW, Wang JZ, Li JC, et al. High-mobility group

protein box-1 and its relevance to cerebral ischemia[J].

J Cereb Blood Flow Metab, 2010, 30:243-254.

20 García-Arnandis I, Guillén MI, Castejón MA, et al.

Haem oxygenase-1 down-regulates high mobility

group box 1 and mat r ix metalloproteinases in

osteoar thr itic synoviocytes[J]. Rheumatology

(Oxford), 2010, 49:854-861.

21 Mack WJ, Mocco J, Hoh DJ, et al. Outcome prediction

with serum intercellular adhesion molecule-1 levels

after aneurysmal subarachnoid hemor rhage[J].

Neurosurg, 2002, 96:71-75.

22 Kubo Y, Ogasawara K, Kakino S, et al. Serum

inflammatory adhesion molecules and high-sensitivity

C-reactive protein correlates with delayed ischemic

neurologic deficits after subarachnoid hemorrhage[J].

Surg Neurol, 2008, 69:592-596.

23 Mocco J, Mack WJ, Kim GH, et al. Rise in serum

soluble intercellular adhesion molecule-1 levels

with vasospasm following aneurysmal subarachnoid

hemorrhage[J]. J Neurosurg, 2002, 97:537-541.

24 Ma t h i e s e n T, Ed n e r G, Ul f a r s s o n E, e t a l .

Cerebrospinal fluid interleukin-1 receptor antagonist

a n d t umo r n e c r o s i s f a c t o r- a lp h a fol lowi n g

subarachnoid hemorrhage[J]. J Neurosurg, 1997,

87:215-220.

25 Gruber A, Rossler K, Graninger W, et al. Ventricular

cerebrospinal f luid and ser um concent rations

of sTNFR-I, IL-1ra, and IL-6 after aneurysmal

subarachnoid hemorrhage[J]. J Neurosurg Anesthesiol,

2000, 12:297-306.

26 Kasuya H, Shimizu T. Act ivated complement

components C3a and C4a in cerebrospinal fluid and

plasma following subarachnoid hemorrhage[J]. J

Neurosurg, 1989, 71:741-746.

27 Ishikawa M, Kusaka G, Yamaguchi N, et al. Platelet

and leukocyte adhesion in the microvasculature at

the cerebral surface immediately after subarachnoid

hemorrhage[J]. Neurosurgery, 2009, 64:546-553.

[1]	于文瑄, 梁冰, 曹永亮. 缺血性视网膜损伤致细胞凋亡的内质网应激机制研究[J]. 中国卒中杂志, 2024, 19(6): 664-671.
[2]	赵鑫, 薛伟, 祝新莉, 井冬青, 洪帆, 郭筱, 刘君玲. 阵发性睡眠性血红蛋白尿症伴可逆性后部脑病综合征1例报道[J]. 中国卒中杂志, 2024, 19(6): 699-705.
[3]	王璐, 张士滨, 吕雪, 杨占君, 贾建新, 吴丽娥. 肉苁蓉总苷经PI3K-Akt信号通路对大鼠脑缺血再灌注损伤的神经保护作用及机制研究[J]. 中国卒中杂志, 2024, 19(11): 1321-1332.
[4]	王超, 胡永珍, 李雪松. 动脉瘤性蛛网膜下腔出血后分流依赖性脑积水的预测研究进展[J]. 中国卒中杂志, 2024, 19(1): 87-93.
[5]	程忻, 仲伟逸, 董漪, 李琦, 倪伟, 谷鸿秋, 顾宇翔, 董强, 中国卒中学会中国脑血管病临床管理指南撰写工作委员会. 中国脑血管病临床管理指南（第2版）（节选）——第6章蛛网膜下腔出血临床管理推荐意见[J]. 中国卒中杂志, 2023, 18(9): 1024-1029.
[6]	李光硕, 赵性泉. 英国国家卒中临床指南2023版要点及解读——出血性卒中[J]. 中国卒中杂志, 2023, 18(12): 1365-1369.
[7]	刘洋, 冯光. 目标温度管理在高分级动脉瘤性蛛网膜下腔出血患者中的应用进展[J]. 中国卒中杂志, 2023, 18(11): 1307-1314.
[8]	霍洁, 陈必耀, 张初吉, 徐玢, 冀瑞俊. 影像学改变及意识障碍与蛛网膜下腔出血继发脑心综合征的相关性研究[J]. 中国卒中杂志, 2023, 18(07): 811-816.
[9]	贺欣, 赵东红, 闫莹, 范艳竹. 蛛网膜下腔出血腰椎穿刺术后患者体位管理新模式的应用效果分析[J]. 中国卒中杂志, 2023, 18(05): 572-576.
[10]	刘健伟, 甄勇, 宋炳伟, 程矫, 耿平, 胡建兵. 高分级动脉瘤性蛛网膜下腔出血患者术后肺炎病原学及耐药性分析 [J]. 中国卒中杂志, 2023, 18(01): 83-89.
[11]	程实, 李静, 郭军平, 胡爱香, 于鑫玮, 韩玮, 梁瑛, 张越巍, 冀瑞俊. 急性卒中患者住院期间感染的临床特征及危险因素分析[J]. 中国卒中杂志, 2022, 17(10): 1065-1070.
[12]	吴倩, 陶立元, 陈思琪, 钟莲梅, 刘丽萍, 米东华. 血糖波动对动脉瘤性蛛网膜下腔出血后迟发性脑缺血及30天死亡的影响 [J]. 中国卒中杂志, 2022, 17(08): 845-850.
[13]	王拥军, 李子孝, 谷鸿秋, 翟屹, 姜勇, 周齐, 赵性泉, 王伊龙, 杨昕, 王春娟, 孟霞, 李昊, 刘丽萍, 荆京, 吴静, 徐安定, 董强, David Wang, 王文志, 马旭东, 赵继宗, 《中国卒中报告》编写委员会（第一作者）. 中国卒中报告2020（中文版）（3）[J]. 中国卒中杂志, 2022, 17(07): 675-682.
[14]	王拥军, 李子孝, 谷鸿秋, 翟屹, 姜勇, 周齐, 赵性泉, 王伊龙, 杨昕, 王春娟, 孟霞, 李昊, 刘丽萍, 荆京, 吴静, 徐安定, 董强, David Wang, 王文志, 马旭东, 赵继宗, 《中国卒中报告》编写委员会（第一作者）. 中国卒中报告2020（中文版）（2）[J]. 中国卒中杂志, 2022, 17(06): 553-567.
[15]	王拥军, 李子孝, 谷鸿秋, 翟屹, 姜勇, 周齐, 赵性泉, 王伊龙, 杨昕, 王春娟, 孟霞, 李昊, 刘丽萍, 荆京, 吴静, 徐安定, 董强, David Wang, 王文志, 马旭东, 赵继宗, 《中国卒中报告》编写委员会（第一作者）. 中国卒中报告2020（中文版）（1）[J]. 中国卒中杂志, 2022, 17(05): 433-447.